ZALSENERTANT TETRAXETAN HYDROCHLORIDE
Chemical
FDA Substance Registry (openFDA)
Chemical Identification
| INCI Name | 2-[[5-(2,6-dimethoxyphenyl)-1-[4-[methyl-[3-[methyl-[3-[methyl-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propyl]amino]propyl]carbamoyl]-2-propan-2-ylphenyl]pyrazole-3-carbonyl]amino]adamantane-2-carboxylic acid;hydrochloride |
|---|---|
| PubChem CID | 165412030 |
| Molecular Formula | C58H85ClN10O13 |
| InChIKey | InChI=1S/C58H84N10O13.ClH/c |
| SMILES | CC(C)C1=C(C=CC(=C1)C(=O)N(C)CCCN(C)CCCN(C)C(=O)CN2CCN(CCN(CCN(CC2)CC(=O)O)CC(=O)O)CC(=O)O)N3C(=CC(=N3)C(=O)NC4(C5CC6CC(C5)CC4C6)C(=O)O)C7=C(C=CC=C7OC)OC.Cl |
Data Sources (1)
| Source | Source ID | Name in Source | Properties |
|---|---|---|---|
| FDA Substance Registry (openFDA) | DQ57E64R2W |
ZALSENERTANT TETRAXETAN HYDROCHLORIDE |
SMS_ID: 300000014381 PUBCHEM: 165412030 FDA UNII: DQ57E64R2W |
Record Info
| ID | 6TVmMnSnZPMAxmrZLTSYEy |
|---|---|
| Created | April 10, 2026, 11:04 p.m. |
| Modified | April 10, 2026, 11:04 p.m. |
| Enriched | April 11, 2026, 12:09 a.m. |
| Data Source | FDA Substance Registry (openFDA) |